Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Internships

Purpose

The purpose of the Cleveland Clinic Main Campus inpatient pharmacy internship program is to provide the knowledge and practical experiences necessary to prepare student pharmacists for residency training or a career in health-system pharmacy after graduation.

Program Details

Our program is a year-round internship consisting of a 12-week summer component from May - August (after P1/P2 coursework) and an average of one out of every four weekends throughout the academic year. The 12-week summer experience includes required rotations in central pharmacy operations, sterile and non-sterile compounding, drug information, and clinical rotations in internal medicine, cardiology, and critical care with electives in other clinical areas based on preceptor availability and each intern’s individual preferences. Additionally, each intern will be assigned projects and/or presentations at the discretion of his or her primary preceptor. The internship start and end dates will be customized based on departmental needs and each intern’s final exam schedule. Ideally, all interns will begin and end on the same dates to provide a consistent and efficient onboarding experience.

Eligibility

Each candidate must have completed a minimum of the first professional year of pharmacy school. It is preferred for candidates to apply during their first professional year as they are then able to participate in the program for two consecutive summers. Offers will be made contingent on the applicant obtaining an Ohio internship license and the ability to work weekends throughout the academic year. Entry into this internship program is competitive and students will be evaluated on various parameters including career goals, prior rotation experience (IPPEs), communication skills, and the ability to work in a dynamic team atmosphere. Candidates should be available for a 30 minute phone or Skype interview in late January or early February.

Applications

Please submit a complete application including a letter of intent, CV and three letters of recommendation by January 6, 2017 to the following email address: ipinternship@ccf.org

All required documents must be submitted in PDF format and letters of recommendation must be signed by the author. Please note that letters of recommendation may also be submitted directly by the author on behalf of an applicant via the email above. Mailed applications are not accepted and incomplete applications will not be considered.

Contact

Allison Eck, PharmD, MS

Manager – Inpatient Pharmacy
Cleveland Clinic
Department of Pharmacy/Hb105
9500 Euclid Avenue
Cleveland, OH 44195
Phone: 216.636.6925
Email: ipinternship@ccf.org

Purpose

The purpose of the community pharmacy summer internship program is to develop knowledge and skills in community pharmacy to assist with patient transition from hospital to ambulatory pharmacy care.

Program Details

Community Pharmacy interns will rotate through a variety of outpatient pharmacy settings within the Cleveland Clinic enterprise including main campus, family health centers, and outpatient pharmacies within community hospitals. Experiences will include: patient consultation, technical functions, medication therapy management, specialty medication services, technology development, and quality assurance. Requirements of the program include a summer project, two presentations, attendance at pharmacy intern meetings and clinical pharmacy conferences. The internship program is currently designed for a 12-week rotation experience during the summer months only; start dates are flexible depending on department and student final exam schedules. The summer internship usually runs May-August each year.

Eligibility

Same as above for inpatient year-round internship program with the exception of weekend requirements during academic year. It is ideal if students can apply during their P1 (of P4 program) year to be considered for two consecutive summers, although P2 candidates will be considered. Ohio internship license is required.

Applications

Please submit a complete application including a letter of intent, CV and three letters of recommendation to the following address: soderm@ccf.org.

Recommendation letters should be in PDF format and must be signed by the author. Recommendation letters may also be submitted separately by the author via the link above. Mailed or incomplete applications will not be accepted.

Contact

Matt Soder

Assistant Director
Ambulatory Pharmacy Services
Cleveland Clinic
Department of Pharmacy
9500 Euclid Avenue/JJN-10
Cleveland, OH 44195
Phone: 216.445.5614
Email: soderm@ccf.org

Purpose

The purpose of the inpatient internship program is to provide knowledge and practical experience necessary for functioning competently and effectively upon licensure in a health-system pharmacy. This internship seeks to prepare students for residency training or careers in a health system beyond graduation.

Program Details

The program is a year-round internship with a 12-week summer component (after P1 coursework) and shift requirements on weeknights and weekends during the academic year. Interns provide core services such as patient counseling, medication reconciliation, oversee bedside delivery services on evenings, and have longitudinal research projects.

The 12-week rotational experience includes rotations such as central pharmacy, sterile and non-sterile compounding, drug information, automation, administration, and clinical experience in internal medicine, ambulatory care, emergency medicine, oncology, and critical care. Requirements of the program include a summer project, and two presentations.

The internship start and end dates are flexible depending on department and student final exam schedules. The summer portion of the internship runs May-August.

Eligibility

The candidate must have completed three years of college coursework including the first professional year in pharmacy school (completed the P3 year of a P6 program or P1 year of a P4 program). It is ideal if students can apply during their P1 year to be considered for two consecutive summers. Applicants must possess an Ohio internship license and be able to work shifts throughout the academic year.

Entry into this internship program is competitive and students will be evaluated on various parameters including career goals, prior rotation experience (IPPEs), communication skills, and ability to work in a dynamic team atmosphere. Candidates should plan for interviews in January.

Applications

Please submit a complete application including a letter of intent, CV, and three references by February 15, 2016 to: MMRxInternship@ccf.org

Contact

Nicole McCorkindale, PharmD
Inpatient Pharmacist
Marymount Hospital
Department of Pharmacy
12300 McCracken Road
Garfield Heights, OH 44125
Phone: 216.587.8269
Email: MMRxInternship@ccf.org

Examples of Student Longitudinal Projects

  • Evaluation of inpatient administration of medications that should be given in HOP setting only (e.g., infliximab, select chemo, etc.)
  • Develop and implement a patient satisfaction survey for the anticoagulation clinics.
  • Develop weekly communication regarding formulary changes, drug shortages and alternatives, and drug recalls, or any other pertinent information from the FDA, etc.
  • IVIG drug usage evaluation in BMT population

Example of Completed Intern Project Abstract

Moxifloxacin Drug Use Evaluation

Purpose 
Moxifloxacin was added to the Cleveland Clinic Formulary in July 2008. It is restricted to penicillin-allergic patients with community-acquired pneumonia (CAP). Ceftriaxone plus azithromycin is the preferred treatment for CAP. Limiting fluoroquinolone use may assist with preventing the emergence of quinolone-resistant isolates. In addition quinolone use, especially moxifloxacin, has been reported with increased C. difficile rates. Therefore, determining if moxifloxacin is prescribed appropriately is important to reduce the possibility of resistance and C. difficile infections.

Methods
A concurrent, non-interventional chart review of patients prescribed moxifloxacin from January 2010-June 2010 was performed. The Cleveland Clinic electronic medical records system (EPIC) was utilized to review and analyze a sample of these patients. Any patient 18 years of age and older who received moxifloxacin was included in the study. Patients treated in the Emergency Department or for tuberculosis (TB) or non-mycobacterial TB were excluded. Data collected included: age, gender, nursing unit, penicillin allergy, type of allergic reaction if applicable, indication for moxifloxacin use, initial formulation of medication, duration of therapy, Infectious Disease consult, and other antimicrobial agents.

Results
165 patients were prescribed moxifloxacin during the time period. 70 patients were reviewed. 18 patients were excluded: four did not receive the medication, 13 were treated in the emergency department, and one was treated for Mycobacteria tuberculosis. A total of 52 patients were analyzed. The average age of the patients was 61 years (± 14 years). The median length of stay (LOS) was nine days (2-36 days). 28 patients were allergic to penicillin with the most common reactions of: rash/itching (nine), hives (five), and anaphylaxis (four). 16 patients were correctly prescribed moxifloxacin (30.7%) according to the restriction. 36 patients did not meet the restriction criteria; the most common indications were: CAP/presumed CAP with no penicillin allergy (13), HAP/HCAP (eight), sinusitis (five), COPD exacerbation (three), and bronchitis (two). In the non-adherence group, the median duration of therapy was three days (1-16 days). Seven non-adherence patients only received one dose and 29 patients were discharged on moxifloxacin. Infectious Disease was consulted for 19 of the non-adherence patients (53%).

Conclusion 
Overall adherence to the restriction appears poor (30.7%). However, a significant portion of use was for patients with penicillin allergies and upper respiratory tract infections. Consideration should be given to expanding the restriction criteria to include other URTIs (e.g., sinusitis, bronchitis) in penicillin allergic patients. Another significant use in the non-adherence group was for the treatment of HAP/HCAP. Ciprofloxacin is the quinolone of choice in this infection due to improved Pseudomonal activity. Finally, the type of penicillin allergy needs to be taken into consideration. Ceftriaxone and azithromycin may be used for non-severe reaction (e.g., rash). Moxifloxacin should not be used when the listed allergy is adverse reaction (e.g. nausea). Education should be provided to the health care team on these matters.